{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:37:36Z","timestamp":1787225856116,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.112072","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T22:12:56Z","timestamp":1713391976000},"page":"112072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["KLRB1 defines an activated phenotype of CD4+\u00a0T cells and shows significant upregulation in patients with primary Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"133","author":[{"given":"Zhonghui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayibaota","family":"Bahabayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainizati","family":"Hasimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingzhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7120-5626","authenticated-orcid":false,"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.intimp.2024.112072_b0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMcp1702514","article-title":"Primary sj\u00f6gren\u2019s syndrome","volume":"378","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.112072_b0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3821","article-title":"Primary Sj\u00f6gren syndrome","volume":"344","author":"Ramos-Casals","year":"2012","journal-title":"BMJ"},{"issue":"9482","key":"10.1016\/j.intimp.2024.112072_b0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sj\u00f6gren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.intimp.2024.112072_b0020","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.arcmed.2006.08.002","article-title":"Pathophysiology of Sj\u00f6gren's syndrome","volume":"37","author":"Garc\u00eda-Carrasco","year":"2006","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.intimp.2024.112072_b0025","article-title":"Epidemiology of primary Sj\u00f6gren's syndrome: a systematic review and meta-analysis","author":"Qin","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.112072_b0030","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-021-23472-7","article-title":"A new molecular classification to drive precision treatment strategies in primary Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Soret","year":"2021","journal-title":"Nat. Commun."},{"issue":"15","key":"10.1016\/j.intimp.2024.112072_b0035","doi-asserted-by":"crossref","first-page":"E579","DOI":"10.1503\/cmaj.122037","article-title":"Sj\u00f6gren syndrome","volume":"186","author":"Mavragani","year":"2014","journal-title":"CMAJ"},{"key":"10.1016\/j.intimp.2024.112072_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.995895","article-title":"Exploiting the role of T cells in the pathogenesis of Sj\u00f6gren\u2019s syndrome for therapeutic treatment","volume":"13","author":"An","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112072_b0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12016-020-08793-7","article-title":"Immunobiology of T cells in Sj\u00f6gren\u2019s syndrome","volume":"60","author":"Yao","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112072_b0050","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/JLB.5MR1020-057RR","article-title":"Follicular helper T cells and follicular regulatory T cells in the immunopathology of primary Sj\u00f6gren\u2019s syndrome","volume":"109","author":"Chen","year":"2021","journal-title":"J Leukocyte Biol"},{"key":"10.1016\/j.intimp.2024.112072_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2014.01.030","article-title":"CD4\u2212 CD8\u2212 T cells in primary Sj\u00f6gren's syndrome: association with the extent of glandular involvement","volume":"51","author":"Alunno","year":"2014","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2024.112072_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.145.1.1","article-title":"Identification of a cell-surface antigen selectively expressed on the natural killer cell","volume":"145","author":"Glimcher","year":"1977","journal-title":"J. Exp. Med."},{"issue":"4974","key":"10.1016\/j.intimp.2024.112072_b0065","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1126\/science.2399464","article-title":"NKR-P1, a signal transduction molecule on natural killer cells","volume":"249","author":"Giorda","year":"1990","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.intimp.2024.112072_b0070","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.cell.2020.02.029","article-title":"SnapShot: natural killer cells","volume":"180","author":"Crinier","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2024.112072_b0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/eji.201343509","article-title":"CD 161++ CD 8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+ IL-18 in a TCR-independent manner","volume":"44","author":"Ussher","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.112072_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114250","article-title":"New insights into MAIT cells in autoimmune diseases","volume":"159","author":"Fan","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.112072_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.613204","article-title":"CD8+ CD161+ T cells: cytotoxic memory cells with high therapeutic potential","volume":"11","author":"Konduri","year":"2021","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.intimp.2024.112072_b0090","first-page":"2647","article-title":"CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines","volume":"121","author":"Pesenacker","year":"2013","journal-title":"Blood, the Journal of the American Society of Hematology"},{"key":"10.1016\/j.intimp.2024.112072_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104507","article-title":"Cytotoxic CD161\u2212 CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus","volume":"90","author":"Xiong","year":"2023","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.intimp.2024.112072_b0100","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/brain\/awq354","article-title":"CD161highCD8+ T cells bear pathogenetic potential in multiple sclerosis","volume":"134","author":"Annibali","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2024.112072_b0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10238-015-0402-1","article-title":"Analysis of the CD161-expressing cell quantities and CD161 expression levels in peripheral blood natural killer and T cells of systemic lupus erythematosus patients","volume":"17","author":"Lin","year":"2017","journal-title":"Clin. Exp. Med."},{"issue":"13","key":"10.1016\/j.intimp.2024.112072_b0110","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.112072_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594658","article-title":"Single-cell RNA sequencing reveals the expansion of cytotoxic CD4+ T lymphocytes and a landscape of immune cells in primary Sj\u00f6gren\u2019s syndrome","volume":"11","author":"Hong","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112072_b0120","article-title":"G protein-coupled receptor 56 characterizes CTLs and reflects the progression of lung cancer patients","author":"Liu","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.112072_b0125","doi-asserted-by":"crossref","first-page":"1128423","DOI":"10.3389\/fimmu.2023.1128423","article-title":"A theoretical framework of immune cell phenotypic classification and discovery","volume":"14","author":"Hu","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112072_b0130","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/j.intimp.2024.112072_b0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2024.112072_b0140","doi-asserted-by":"crossref","first-page":"1017157","DOI":"10.3389\/fimmu.2022.1017157","article-title":"In patients with primary Sj\u00f6gren's syndrome innate-like MAIT cells display upregulated IL-7R, IFN-\u03b3, and IL-21 expression and have increased proportions of CCR9 and CXCR5-expressing cells","volume":"13","author":"Hinrichs","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.intimp.2024.112072_b0145","article-title":"A pancancer analysis of CD161, a potential new immune checkpoint","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112072_b0150","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.188.5.867","article-title":"CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V\u03b124J\u03b1Q T-cell receptor \u03b1 chains","volume":"188","author":"Exley","year":"1998","journal-title":"J. Exp. Med."},{"issue":"55","key":"10.1016\/j.intimp.2024.112072_b0155","doi-asserted-by":"crossref","first-page":"eabe2749","DOI":"10.1126\/sciimmunol.abe2749","article-title":"Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4R\u03b1 blockade","volume":"6","author":"Bangert","year":"2021","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112072_b0160","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/rheumatology\/keaa105","article-title":"Lymphopenia in primary Sj\u00f6gren\u2019s syndrome is associated with premature aging of na\u00efve CD4+ T cells","volume":"60","author":"Fessler","year":"2021","journal-title":"Rheumatology"},{"issue":"23","key":"10.1016\/j.intimp.2024.112072_b0165","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1158\/1078-0432.CCR-06-0977","article-title":"Increased frequency of CD4+ cells expressing CD161 in cancer patients","volume":"12","author":"Iliopoulou","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2024.112072_b0170","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/hep.22040","article-title":"CD161 expression on hepatitis C virus\u2013specific CD8+ T cells suggests a distinct pathway of T-cell differentiation","volume":"47","author":"Northfield","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2024.112072_b0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri1052","article-title":"Cytokine control of memory T-cell development and survival","volume":"3","author":"Schluns","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112072_b0180","first-page":"1","article-title":"Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-\u03b3 is a major determinant of CD4+ CAR T-cell antitumour activity","author":"Boulch","year":"2023","journal-title":"Nat. Cancer"},{"issue":"11","key":"10.1016\/j.intimp.2024.112072_b0185","doi-asserted-by":"crossref","first-page":"e2241451","DOI":"10.1001\/jamanetworkopen.2022.41451","article-title":"Efficacy and safety of low-dose interleukin 2 for primary sj\u00f6gren syndrome: A randomized clinical trial","volume":"5","author":"He","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.intimp.2024.112072_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar3348","article-title":"Disturbance of cytokine networks in Sj\u00f6gren's syndrome","volume":"13","author":"Youinou","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.intimp.2024.112072_b0195","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/eji.200940257","article-title":"CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC","volume":"40","author":"Maggi","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.112072_b0200","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-biophys-051013-022942","article-title":"What do structures tell us about chemokine receptor function and antagonism?","volume":"46","author":"Kufareva","year":"2017","journal-title":"Annu. Rev. Biophys."},{"issue":"5793","key":"10.1016\/j.intimp.2024.112072_b0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/289071a0","article-title":"Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor","volume":"289","author":"Capron","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112072_b0210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.1997.tb46238.x","article-title":"Phagocyte chemoattractant receptors","volume":"832","author":"Boulay","year":"1997","journal-title":"Ann. n. y. Acad. Sci."},{"issue":"16","key":"10.1016\/j.intimp.2024.112072_b0215","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.intimp.2024.112072_b0220","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/1568008043339712","article-title":"Chemokine-chemokine receptor network in immune cell trafficking","volume":"4","author":"Kim","year":"2004","journal-title":"Current Drug Targets-Immune, Endocrine & Metabolic Disorders"},{"issue":"4","key":"10.1016\/j.intimp.2024.112072_b0225","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000087185","article-title":"Chemokine receptor CCR1: a new target for progressive kidney disease","volume":"25","author":"Ninichuk","year":"2005","journal-title":"Am. J. Nephrol."},{"issue":"6824","key":"10.1016\/j.intimp.2024.112072_b0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.112072_b0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and chemokine receptors: new targets for cancer immunotherapy","volume":"10","author":"Mollica Poeta","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112072_b0240","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/path.4123","article-title":"Regulation of the immune and inflammatory responses by the'atypical'chemokine receptor D6","volume":"229","author":"Graham","year":"2013","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112072_b0245","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/rheumatology\/kew360","article-title":"Clinical relevance of ROR\u03b3 positive and negative subsets of CD161+CD4+ T cells in primary Sj\u00f6gren's syndrome","volume":"56","author":"Zhao","year":"2017","journal-title":"Rheumatology (oxford)"},{"key":"10.1016\/j.intimp.2024.112072_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/307453","article-title":"The Clinical Relevance of IL-17-Producing CD4+CD161+ Cell and Its Subpopulations in Primary Sj\u00f6gren's Syndrome","volume":"2015","author":"Li","year":"2015","journal-title":"J Immunol Res"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924005903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924005903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T20:06:20Z","timestamp":1715630780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924005903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":50,"alternative-id":["S1567576924005903"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112072","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KLRB1 defines an activated phenotype of CD4+\u00a0T cells and shows significant upregulation in patients with primary Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112072"}}